RePORT International Resources

Good Clinical Laboratory Practice (GCLP) is a set of guidelines describing the application of those Good Laboratory Practice principles that are relevant to the analyses of samples from clinical trials while ensuring the purpose and objectives of the Good Clinical Practice principles are maintained. In so doing, the reliability, quality, consistency and integrity of data generated by clinical trial laboratories can be assure which is crucial to the outcome of any clinical trial.

This ICH E6 GCP Investigator Site Training, in multiple languages, meets the Minimum Criteria for ICH GCP Investigator Site Personnel Training identified by TransCelerate BioPharma as necessary to enable mutual recognition of GCP training among trial sponsors.

New course - free and online - Research Ethics Online Training (V2)

The templates have been shared by groups, and are free to use and adapt for individual's research studies.

Our research team is accepting applications for a postdoctoral fellowship based in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health under the mentorship of Dr. David Dowdy and Dr. Emily Kendall. The start date for these fellowships is flexible, but preference will be given to applicants who can start by June 2026. According to JHU policy, appointments will be for one year, renewable by mutual agreement – our hope is to recruit a fellow who is interested in a two-year fellowship. We are seeking fellows with a background in mathematical modeling and cost-effectiveness analysis, and interest in combining these tools with both primary and secondary data sources to answer policy-relevant questions about tuberculosis interventions. Reflecting our team-based, collaborative approach to research, fellows will work with a broader mentorship team, with additional mentors drawn from the Center for Tuberculosis Research and other collaborating teams as appropriate. This fellowship will be funded from a combination of four specific projects (described below), providing flexibility to structure the fellowship around the goals of individual applicants. Successful fellows will help broaden our team’s horizons, enabling us to build new collaborations and explore new research areas. The specific deliverables for this fellowship are linked to ongoing field-based studies with empiric data collection, including: . Models of the impact and cost-effectiveness of school-based screening and prevention in India. Estimating the long-term impact and cost-effectiveness of school-based TB disease screening, with or without the addition of preventive therapy for people with infection . Models of the impact and cost-effectiveness of venue-targeted vaccination programs in Zambia, Nigeria, and Indonesia. Evaluating whether vaccination is more efficient when delivered at specific venues (e.g., prisons, mines, bars) than to the general population or at health facilities . Models of the impact and cost-effectiveness of novel diagnostic assays for tuberculosis. Understanding the importance of different design characteristics and implementation strategies for novel diagnostics, particularly those intended for children, screening, and/or drug susceptibility testing . Models of the impact and cost-effectiveness of drug susceptibility testing for bedaquiline. Forecasting the future and health impact of bedaquiline-resistant TB under different scenarios of availability and scale-up of drug susceptibility testing in key countries Applicants must have: . A recent PhD (or MD) degree in a relevant discipline (expected graduation in Spring 2026 is acceptable). . Strong quantitative background, with demonstrated ability to program in one or more scientific programming languages, e.g. R, Python, C++, etc. . Demonstrated ability to lead modeling research, as well as strong communication and writing skills. . Ability to work independently, function as part of a highly collaborative, interdisciplinary, open-source-oriented team, and contribute to biweekly team meetings and journal clubs. Application Procedures Interested applicants should submit the following via a single email to Dr. Dowdy (ddowdy1@jhmi.edu): - Cover letter describing research interests, career goals, and prior experience - Curriculum vitae - Contact information of 3 references (to be contacted only after first discussing with the applicant) Applications submitted by January 31 will be given priority. Initial interviews will be held in Feb 2025 and selections made promptly. We encourage applications regardless of precise timeline or current location, and we will work with qualified candidates to sort out hiring details and timelines. Please contact Dr. Dowdy and/or Dr. Kendall (ekendall@jhmi.edu) by email with any questions.

DEADLINE: January 2026 SEPTRE (SPIRIT Electronic Protocol Tool and Resource) is an innovative, web-based software solution that makes it easier to create, manage, and register high-quality protocols for clinical trials. From now until January 2026, The Global Health Network and EDCTP have a limited number of free individual three-year SEPTRE licenses for researchers based in low-resource settings.

Member benefits include: Being part of a tropical medicine and global health community Discounts for RSTMH events and access to travel scholarships Access to our peer-reviewed journal, Transactions Professional networking and opportunities for collaboration Eligibility to nominate and be nominated for RSTMH Medals and Awards Access to the RSTMH Members Area with exclusive content, announcements, and offers A 20% discount on open access fees for our journals International Health, Transactions and Artificial Intelligence in Global Health Eligibility to apply to our Country Ambassador and Student Ambassador programmes Access to our online Members Directory Enhancements to your professional knowledge Opportunities to share your expertise and learn from established experts in the field A fortnightly newsletter that contains exclusive news and opportunities for our members A 25% discount on thousands of Oxford University Press books Supporting RSTMH’s vision

The TBPod is a podcast for clinicians and policymakers caring for patients with tuberculosis. The podcasts present discussions with expert clinicians, researchers, policymakers and advocates about their work in the field of tuberculosis. Tuberculosis remains one of the leading causes of death worldwide, and is an important contributor to morbidity among migrants arriving in Australia and New Zealand. There are around 1300 reported cases of TB in Australia each year, and a further 300 in New Zealand. Included in these figures are cases of multi-drug resistant (MDR) TB which pose significant barriers to treatment and management of the disease. The Australian government has committed to the global elimination of TB by 2030, but to do so requires the development of innovative new strategies, based on high-quality research, that has national and international reach. These podcasts aim to engage and update those who are interested in the field of tuberculosis through discussions with leaders in the field of tuberculosis.

The TBPod is a podcast for clinicians and policymakers caring for patients with tuberculosis. The podcasts present discussions with expert clinicians, researchers, policymakers and advocates about their work in the field of tuberculosis. These podcasts aim to engage and update those who are interested in the field of tuberculosis through discussions with leaders in the field of tuberculosis.

Abstract, Travel Grant, and Challenging Case Submissions Now Open Deadline for Submissions: 21 September 2026 February 24 – 28, 2027 | Vancouver, BC, Canada The 2027 End TB Conference of the Union North American Region is looking forward to holding its 31st annual conference at the Sheraton Vancouver Wall Centre Hotel, 1000 Burrard St, Vancouver, BC, Canada, from February 24-27, 2027. We hope that you will join us in person to participate in our pre-conference postgraduate sessions and stay to attend our full conference. Please visit our website for ongoing conference program updates as we finalize our agenda over the next few months. We look forward to seeing to both new and familiar faces in support of the North American TB community.

The "Atlas of TB Innovations" is catalogue of all innovations in the fight against Tuberculosis (TB). Innovations showcases cutting-edge solutions, breakthrough technologies and transformative ideas that drive progress. Explore advancements shaping the future across various industries.

The Atlas of TB innovations is envisioned to be the updated single point reference for all innovations in the fight against Tuberculosis. It will catalogue scientific, technological, and operational advancements being made by innovators across the world. The Atlas will keep track of each innovations as they mature in its implementation and obtain certainty in its effectiveness and reliability, while securing various regulatory approvals. For each innovation on the Atlas, it showcases: 1. Live Status - of the innovation in the product maturity/ scaleup pathway and future trajectory 2. Value add - of the innovation in care process/ cascade/ programmatic protocols

The PHA Editors will consider any manuscript reporting original research on progress to achieving the SDGs. Suitable topics include infection-related topics such as vaccines, infection prevention control, outbreaks and antimicrobial resistance. Non-communicable diseases of public health importance include nutrition, the impact of climate change and planetary health. The journal aims to improve public health practice and we welcome operational research, lessons from implementation and evaluations of public health interventions. We will also consider submissions that focus on issues related to health care access and universal health coverage, quality, efficiency, cost-effectiveness, ethics and equity as well as education and training.

In-person courses and virtual options, too - Free online courses We currently offer the following online courses, free of charge: How to develop a research grant proposal (English) Interpretation of CXR in children with presumptive TB (English) Interpretation of CXR in adults (French) Prevent TB: management of TB infection (English, French and Spanish)

You must first log in to the Union site to access these courses.

This webinar highlights recent challenges related to M. Bovis management.

The app still offers the same comprehensive range of courses from The Union, equipping you and your team with the skills to effectively treat and manage tuberculosis – using the latest insights from leading experts around the world.

The Union Free Online Courses: Online course for chest radiograph interpretation for diagnostics of TB in adults (English) Drug-resistant tuberculosis: from clinical to programmatic (English) Course on tobacco cessation for health care professionals (French) Online course on the management of child and adolescent tuberculosis (English) How to develop a research grant proposal (English) Interpretation of CXR in children with presumptive TB (English) Interpretation of CXR in adults (French)

This webinar recording provides some tips on how to write scientific abstracts for The Union conference.